PDL Biopharma Inc., of Incline Village, Nev., said it received $30.3 million, in addition to previously received revenue interest payments, to conclude PDL's revenue interest agreement with regenerative medicine company Axogen Inc., of Alachua, Fla. In October 2012, PDL entered a structured financing transaction in which it provided Axogen with an aggregate of $20.8 million in exchange for royalties on certain Axogen revenues.